Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
Customer Reviews: What Real Users Say What people praise: Customer service dominates the positive reviews
111 This trial included 16,645 healthy men, non-pregnant women, and people with chronic diseases aged 1884 without COVID-19 infection and immune disease history
resolves between titrations Week 58 (retatrutide ~1 mg/week) Steady weight-loss rate (community-reported 12 lb/week) "Food noise" reduction strongest at this dose GI side effects easing as the body adapts to the stable dose Week 912 (retatrutide ~2 mg/week, maintenance entry point) Stable weight-loss curve Rate of loss consistent with retatrutide Phase 2 trajectory This is the reported entry point for adding cagrilintide By month 3, community-reported total weight loss on retatrutide alone clusters around 610%
The side effects of low-dose methylene blue are generally mild, but can include several notable adverse reactions
Furthermore, a gradual taper can help minimize other potential side effects
